High-Performance Liquid Chromatography of MDL-035 in the Plasma of Rats,Dogs and Humans

Abstract

A sensitive and reproducible high performance liquid chromatographic method was set up for the assay of MDL-035, a new non-steroidal, nonacidic analgesic antiinflammatory agent, in the plasma of rats, dogs and humans. Plasma samples (0.5ml) containing flurazepam as the internal standard, were diluted and extracted with ethyl ether. After centrifugation, the organic phase was taken to dryness, the residue was redissolved and injected into an RP-2 column. The elution was made in isocratic conditions using a CH.CN/phosphate buffer solution as mobile phase. The UV detection was made at 320 nm. The method was validated for the concentration range from 0.05 to 10 ug/ml, and applied to pharmacokinetic studies. A typical plasma concentration-time profile in the rat after an oral administration is here presented.